To investigate the correlation between METTL3 and USP25, we analyzed the protein levels of USP25 and METTL3 in a broad panel of cancer cell lines and 37 clinical glioma samples, along with 11 brain tissues from patients with non-tumor (Figures 3A and S4A). Here, METTL3 is linked to central nervous system cancer.